77 related articles for article (PubMed ID: 36372245)
21. Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL; Del Prato S; Rosenstock J; Butler J; Ezekowitz J; Ibrahim NE; Lam CSP; Marwick T; Wilson Tang WH; Liu Y; Mohebi R; Urbinati A; Zannad F; Perfetti R
Cardiovasc Diabetol; 2024 Feb; 23(1):49. PubMed ID: 38302936
[TBL] [Abstract][Full Text] [Related]
22. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Perfetti R; Rosenstock J; Solomon SD; Tang WHW; Zannad F
J Am Coll Cardiol; 2024 Jul; 84(2):137-148. PubMed ID: 38597864
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center.
Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR
BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169
[TBL] [Abstract][Full Text] [Related]
24. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
Januzzi JL; Butler J; Del Prato S; Ezekowitz JA; Ibrahim NE; Lam CSP; Lewis GD; Marwick TH; Rosenstock J; Tang WHW; Zannad F; Lawson F; Perfetti R; Urbinati A
Am Heart J; 2023 Feb; 256():25-36. PubMed ID: 36372245
[TBL] [Abstract][Full Text] [Related]
25. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
[TBL] [Abstract][Full Text] [Related]
26. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
27. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
Huang Q; Liu Q; Ouyang D
Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
[TBL] [Abstract][Full Text] [Related]
28. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
29. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach.
Nesti L; Pugliese NR; Sciuto P; Natali A
Cardiovasc Diabetol; 2020 Sep; 19(1):134. PubMed ID: 32891175
[TBL] [Abstract][Full Text] [Related]
30. [Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications].
Nishimura-Yabe C
Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):137-45. PubMed ID: 9583077
[TBL] [Abstract][Full Text] [Related]
31. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
Molecules; 2021 May; 26(10):. PubMed ID: 34066081
[TBL] [Abstract][Full Text] [Related]
32. Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC; Abel ED
Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
[TBL] [Abstract][Full Text] [Related]
33. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
34. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
Heather LC; Gopal K; Srnic N; Ussher JR
Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
